BIO 2018: Gottlieb defends naming drug makers, outlines office efforts
08-06-2018
BIO 2018: Former judge weighs in on differing patent standards
06-06-2018
tumsasedgars / iStockphoto.com
“The Saint Regis Mohawk Tribe issue is not unique to just life sciences—we’re likely to see it across the board. There’s likely been other transfers that are not yet public information,” said Teresa Rea, vice-chair of Crowell & Moring’s IP group and former director of the US Patent and Trademark Office (USPTO).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teresa Rea, USPTO, BIO 2018, Saint Regis Mohawk Tribe, Allergan, sovereign immunity
